Clinical Study of Fulvestrant Combined With Chidamide in the Treatment of Hormone Receptor-positive Advanced Breast Cancer Resistant to CDK4/6 Inhibitors
Clinical trial NCT05191914 · UNKNOWN
Trial details
- NCT number
- NCT05191914
- Sponsor
- Liaoning Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-07
- Primary completion
- 2022-07-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.